Q2 2024 · 13F-HR
Bruce & Co., Inc.holdings as filed
Filed 2024-08-09 · accession 0001104659-24-087704
$304.0M
Reported value
40
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 023586506 | UHAL/B | Uhaul B | $32.6M | 10.7% | 542,950 | Common | SOLE |
| 589331107 | — | Merck | $27.8M | 9.14% | 224,500 | Common | SOLE |
| 00287Y109 | ABBV | Abbvie | $27.7M | 9.11% | 161,500 | Common | SOLE |
| 302571104 | — | Nextera Energy | $23.6M | 7.76% | 333,300 | Common | SOLE |
| 020002101 | ALL | Allstate | $20.8M | 6.85% | 130,500 | Common | SOLE |
| 26441C204 | DUK | Duke Energy | $20.6M | 6.79% | 205,816 | Common | SOLE |
| 125896100 | CMS | CMS Energy | $19.0M | 6.27% | 320,000 | Common | SOLE |
| 00206R102 | T | AT & T | $18.8M | 6.19% | 984,000 | Common | SOLE |
| 002824100 | ABT | Abbott | $15.8M | 5.21% | 152,300 | Common | SOLE |
| 45774W108 | IIIN | Insteel | $10.6M | 3.50% | 343,423 | Common | SOLE |
| 98389B100 | XEL | XEL Energy | $10.5M | 3.44% | 196,000 | Common | SOLE |
| 037833100 | AAPL | Apple | $8.4M | 2.75% | 39,700 | Common | SOLE |
| 717081103 | PFE | Pfizer | $7.7M | 2.54% | 276,400 | Common | SOLE |
| 05379B107 | AVA | Avista | $7.0M | 2.29% | 201,500 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients | $5.5M | 1.81% | 150,000 | Common | SOLE |
| H11356104 | BG | Bunge | $5.3M | 1.76% | 50,000 | Common | SOLE |
| 023586100 | UHAL | Uhaul | $4.6M | 1.53% | 75,105 | Common | SOLE |
| 651639106 | NEM | Newmont | $4.2M | 1.38% | 100,000 | Common | SOLE |
| 91911K102 | — | Bausch Health | $3.8M | 1.26% | 550,000 | Common | SOLE |
| 00484MAB2 | — | Acorda Theraputics | $3.5M | 1.15% | 5,000,000 | Common | SOLE |
| 749607107 | RLI | RLI | $3.2M | 1.04% | 22,400 | Common | SOLE |
| 039483102 | ADM | Archer Daniels | $3.0M | 0.99% | 50,000 | Common | SOLE |
| 268311107 | EDAP | EDAP | $3.0M | 0.99% | 553,652 | Common | SOLE |
| 925815102 | VICR | Vicor | $2.3M | 0.76% | 70,000 | Common | SOLE |
| 868459108 | SUPN | Supernus | $2.2M | 0.72% | 82,105 | Common | SOLE |
| 82968B103 | SIRIEUR | XM Sirius | $1.6M | 0.52% | 557,843 | Common | SOLE |
| 044209104 | — | Ashland | $1.4M | 0.47% | 15,000 | Common | SOLE |
| N51517105 | 4PKB | Lava Theraputics | $1.4M | 0.46% | 771,874 | Common | SOLE |
| 00430HAC6 | — | Accelerate Diagnostic | $1.3M | 0.42% | 3,212,268 | Common | SOLE |
| 56400P706 | MNKD | Mannkind | $1.0M | 0.33% | 195,073 | Common | SOLE |
| 50015M109 | KOD | Kodiak Sciences | $994,050 | 0.33% | 423,000 | Common | SOLE |
| 31189P102 | FATE | Fate Theraputics | $984,000 | 0.32% | 300,000 | Common | SOLE |
| 449585108 | 1K0 | IGM Bioscience | $687,000 | 0.23% | 100,000 | Common | SOLE |
| 68622V106 | OGN | Organon | $649,359 | 0.21% | 31,370 | Common | SOLE |
| 92556V106 | VTRS | Viatris | $625,395 | 0.21% | 58,833 | Common | SOLE |
| 142038108 | CRBU | Caribou Biosciences | $492,000 | 0.16% | 300,000 | Common | SOLE |
| 92939U106 | WEC | WEC Energy | $353,776 | 0.12% | 4,509 | Common | SOLE |
| 65443P102 | MASS | 908 Devices | $351,673 | 0.12% | 68,286 | Common | SOLE |
| 71535D106 | PSNL | Personalis | $351,000 | 0.12% | 300,000 | Common | SOLE |
| 934423104 | WBD | Warner Bros. Discovery | $88,171 | 0.03% | 11,851 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.